Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Kratki znanstveni prispevek
Oznake: cardiovascular disease;chronic kidney disease;CGM;CKM;diabetes;finerenone;GLP-1 RA;guidelines;heart failure;MASLD;obesity;SGLT2 inhibitor;tirzepatide;
The 10th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on December 5–6, 2024. This year, discussions about cardiovascular (CV) and kidney outcome trials centered on the recent findings from studies involving empagliflozin (E ...
Leto: 2025 Vir: Medicinska fakulteta (UL MF)
Pregledni znanstveni članek
Oznake: ultra-rapid-acting insulin;URLi;faster aspart;insulin therapy;type I diabetes;type 2 diabetes;
Ultra-rapid-acting insulin analogs (URAA) are a further development and refinement of rapid-acting insulin analogs. Because of their adapted formulation, URAA provide an even faster pharmacokinetics and thus an accelerated onset of insulin action than conventional rapid-acting insulin analogs, allow ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Kratki znanstveni prispevek
Oznake: sladkorna bolezen;srčnožilne bolezni;srčni zastoj;kronična ledvična bolezen;
Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exchange on recently completed outcomes trials including dapagliflozin (DAPA-MI), semaglutide (SELECT and STEP-HFpE ...
Leto: 2024 Vir: Medicinska fakulteta (UL MF)
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: